Preliminary study featured the continuous subcutaneous infusion of GLP-1 over a duration of six weeks showed an effective decreases in fasting and postprandial glucose levels, as well as involved enhancements in A1C, improvement in insulin sensitivity and body weight (Zander et al
98 (4):E664-671 43
Co-delivery of indomethacin and uricase as a new strategy for inflammatory diseases associated with high uric acid
medicines in the same class can have different active ingredients and labeling
It is important to note that claims about increased energy expenditure in humans remain insufficiently evidenced at this stage, and the net glycaemic effects reflect observed trial outcomes rather than a straightforward mechanistic reduction in hepatic glucose output the concurrent glucagon receptor agonism may, in fact, influence hepatic glucose production in a complex and not fully characterised manner
More competition in the GLP-1 drug class, including the introduction of oral formulations, is expected to impact price, she said